-
Development of Nanobodies as Novel Tools to Characterize LRRK2 as a Potential Drug Target for Parkinson's Disease
… (accelerates chemical reactions) functions. Targeting the multiple enzymatic functions of LRRK2 represents a very … fragments derived from a special type of antibodies (immune system cells) present in camelids such as llamas. In recent …
-
Therapeutic Development of Novel STING Inhibitors to Treat Parkinson's Disease Neuroinflammation
… We will also conduct IND-enabling toxicology studies in multiple preclinical models. Impact on Diagnosis/Treatment … toxicology studies, we will complete a full assessment of systemic and CNS metrics. We also plan to engage interested …
-
Ahead of First National Parkinson’s Project Advisory Council Meeting, Leading Parkinson’s Organizations Call for Urgent Action
June 25, 2026
… impose growing costs on individuals, families, health care systems and the national economy — totaling an estimated … palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). As a catalyst for new treatments and a cure, …
-
Team Big B: How Honoring Brian Adam Turned 100 Miles into Impact
December 22, 2025
… of Big B. I watched Brian battle Parkinson’s disease and Multiple System Atrophy for years, and he faced the disease and the daily …
-
Alberto Ascherio, MD, DrPH
… Alberto Ascherio leads multiple NIH-funded projects involving both national and … Ascherio has developed the skills to efficiently manage the multiple steps of scientific research, from study design and … the past 25 years, he has direction the investigations of multiple sclerosis (MS), Parkinson’s disease (PD) and …
-
Anthony B. Pinkerton, PhD
… (San Diego). Over his career Dr. Pinkerton has worked in multiple areas including CNS, virology, diabetes, … for in-licensing efforts and competitive intelligence for multiple targets, in addition to developing IP strategies around multiple chemical series. In addition to numerous …